论文部分内容阅读
从1980年以来,我所应用舒必利治疗精神分裂症48例,现将其近期疗效报告如下。一、资料:48例精神分裂症在病程及类型方面未作任何选择。48例均属男性。发病年龄在17—60岁,多数在20—40岁。病程1—3年10例,3—5年14例,10年以上24例。二、方法:本组舒必利用量一般开始日量300mg,最高日量1500mg,多数为600—900mg。达到治疗量后维持6—8周。治疗过程中未合用其它抗精神病药。在治疗前、中、后均作血尿常规及肝功能检查。三、近期疗效观察:本组48例的疗效(疗
Since 1980, we have applied sulpiride to treat 48 cases of schizophrenia, and its recent efficacy is reported below. First, the data: 48 cases of schizophrenia in the course and type did not make any choice. 48 cases are men. The age of onset in the 17-60 years old, mostly in the 20-40 years old. Duration of 1-3 years in 10 cases, 3-5 years in 14 cases, more than 10 years in 24 cases. Second, methods: The amount of sulpiride in this group generally start the day 300mg, the maximum daily dose of 1500mg, the majority of 600-900mg. After reaching the treatment volume for 6-8 weeks. No other antipsychotics were used during treatment. In the treatment before, during, after hematuria routine and liver function tests. Third, the recent observation of efficacy: The efficacy of this group of 48 patients (treatment